Patient Organizations ’ Barriers in Pharmacovigilance and Strategies to Stimulate Their Participation

ConclusionBoth study phases show congruent results regarding patients ’ involvement and the activities patient organizations perform to promote drug safety. Patient organizations progressively position themselves as stakeholders in PV, carrying out many activities that stimulate awareness and participation of their members in drug safety, but still face internal and external barriers that can hamper their involvement.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research